ライフスタンスヘルス社は2025年に利益を得て,純利益970万ドルと1424億ドルもの収益を報告し,強力な成長と1億ドルの株式買い戻しを行いました. LifeStance Health turned profitable in 2025, reporting $9.7M net income and $1.424B revenue, with strong growth and a $100M stock buyback.

ライフスタンスヘルスグループは2025年に公開会社として初の年間収益性を報告し,純利益970万ドルと収益1424億ドルを記録し,訪問量と臨床医の増加により,同比14%の増加となった. LifeStance Health Group reported its first annual profitability as a public company in 2025, posting net income of $9.7 million and revenue of $1.424 billion, a 14% increase year-over-year, driven by higher visit volumes and clinician growth. 同社は4四半期に4900万ドルの調整済EBITDAを記録し,49%増加し,1億ドルの株式買い戻しプログラムを発表した. The company achieved record fourth-quarter Adjusted EBITDA of $49 million, up 49%, and announced a $100 million share repurchase program. 2026年には,ライフスタンスが1615億から1655億ドルの収益を予測し,調整済みのEBITDAは185百万から205百万米ドルで,継続的な運用改善,AI主導の効率向上,新しい電子医療記録システムなどに言及しています. For 2026, LifeStance projected revenue between $1.615 billion and $1.655 billion, with adjusted EBITDA of $185 million to $205 million, citing ongoing operational improvements, AI-driven efficiency gains, and a new electronic health record system.